Cytocompatibility of Porous Biphasic Calcium Phosphate Granules With Human Mesenchymal Cells by a Multiparametric Assay

Artificial Organs

Volumn 36, Issue 6, 2012, Pages 535-542

  Mitri, Fabio ^a,b   Alves, Gutemberg ^b,c   Fernandes, Gustavo ^c   König, Bruno ^e   Rossi Jr , Alexandre ^d   Granjeiro, Jose ^b,c  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c HOSPITAL UNIVERSITÁRIO ANTÔNIO PEDRO   (Brazil)

^d CENTRO BRASILEIRO DE PESQUISAS FÍSICAS   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biocompatibility; Biphasic calcium phosphate; Stem cells; Tissue engineering

Indexed keywords

CALCIUM PHOSPHATE; CELL ENGINEERING; CYTOLOGY; EXTRACTION; GRANULATION; HYDROXYAPATITE; SCANNING ELECTRON MICROSCOPY; STEM CELLS; TISSUE ENGINEERING;

BIPHASIC CALCIUM PHOSPHATE GRANULES; BIPHASIC CALCIUM PHOSPHATES; CYTOCOMPATIBILITY; DENSE MATERIALS; MESENCHYMAL CELLS; POROUS HYDROXYAPATITE; PRESSUNG; STEM-CELL; TISSUES ENGINEERINGS; Β-TCP;

BIOCOMPATIBILITY;

BIOCERAMICS; BIPHASIC CALCIUM PHOSPHATE; CALCIUM ION; CALCIUM PHOSPHATE; CRYSTAL VIOLET; HYDROXYAPATITE; NEUTRAL RED; UNCLASSIFIED DRUG; [2,3 BIS(2 METHOXY 4 NITRO 5 SULFOPHENYL) 5 [(PHENYLAMINO)CARBONYL] 2H TETRAZOLIUM HYDROXIDE];

ARTICLE; BIOCOMPATIBILITY; BIOENGINEERING; BONE REGENERATION; CELL ACTIVITY; CELL ASSAY; CELL DENSITY; CELL GRANULE; CELL SURFACE; CELL VIABILITY; CERAMICS; COMPOSITE MATERIAL; CONTROLLED STUDY; CULTURE MEDIUM; CYTOCOMPATIBILITY; ELUTION; EXTRACTION; GRINDING; HUMAN; HUMAN CELL; MESENCHYME CELL; MITOCHONDRION; MULTIPARAMETRIC ASSAY; POROSITY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SIEVING; THERMAL EXPOSURE;

EID: 84862235871     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2011.01409.x     Document Type: Article

References (35)

1. Rosen PS, Reynolds MA, Bowers GM. The treatment of intrabony defects with bone grafts. Periodontol 2000 2000;22:88-103.
2. Ohgushi H, Miyake J, Tateishi T. Mesenchymal stem cells and bioceramics: strategies to regenerate the skeleton. Novartis Found Symp 2003;249:118-27.
3. Sanchez-Salcedo S, Balas F, Izquierdo-Barba I, Vallet-Regi M. In vitro structural changes in porous HA/beta-TCP scaffolds in simulated body fluid. Acta Biomater 2009;5:2738-51.
4. Kamitakahara M, Ohtsuki C, Miyazaki T. Review paper: behavior of ceramic biomaterials derived from tricalcium phosphate in physiological condition. J Biomater Appl 2008;23:197-212.
5. LeGeros RZ, Lin S, Rohanizadeh R, Mijares D, LeGeros JP. Biphasic calcium phosphate bioceramics: preparation, properties and applications. J Mater Sci Mater Med 2003;14:201-9.
6. Arinzeh TL, Tran T, Mcalary J, Daculsi G. A comparative study of biphasic calcium phosphate ceramics for human mesenchymal stem-cell-induced bone formation. Biomaterials 2005;26:3631-8.
7. Liu X, Ma PX. Polymeric scaffolds for bone tissue engineering. Ann Biomed Eng 2004;32:477-86.
8. Gbureck U, Holzel T, Biermann I, Barralet JE, Grover LM. Preparation of tricalcium phosphate/calcium pyrophosphate structures via rapid prototyping. J Mater Sci Mater Med 2008;19:1559-63.
9. Ruano R, Jaeger RG, Jaeger MM. Effect of a ceramic and a non-ceramic hydroxyapatite on cell growth and procollagen synthesis of cultured human gingival fibroblasts. J Periodontol 2000;71:540-5.
10. Yang HY, Thompson I, Yang SF, Chi XP, Evans JR, Cook RJ. Dissolution characteristics of extrusion freeformed hydroxyapatite-tricalcium phosphate scaffolds. J Mater Sci Mater Med 2008;19:3345-53.
11. Denissen HW, Klein CP, Visch LL, van den Hooff A. Behavior of calcium phosphate coatings with different chemistries in bone. Int J Prosthodont 1996;9:142-8.
12. Ong JL, Bessho K, Cavin R, Carnes DL. Bone response to radio frequency sputtered calcium phosphate implants and titanium implants in vivo. J Biomed Mater Res 2002;59:184-90.
13. Yang Y, Bumgardner JD, Cavin R, Carnes DL, Ong JL. Osteoblast precursor cell attachment on heat-treated calcium phosphate coatings. J Dent Res 2003;82:449-53.
14. ISO. ISO 10993-05: biological evaluation of medical devices-Part 5: tests for in vitro cytotoxicity. ISO 10993-12:2007, International Organization for Standardization, 2009.
15. Alcaide M, Serrano MC, Pagani R, Sanchez-Salcedo S, Vallet-Regi M, Portoles MT. Biocompatibility markers for the study of interactions between osteoblasts and composite biomaterials. Biomaterials 2009;30:45-51.
16. Alcaide M, Serrano MC, Pagani R, etal. L929 fibroblast and Saos-2 osteoblast response to hydroxyapatite-betaTCP/agarose biomaterial. J Biomed Mater Res A 2009;89:539-49.
17. Fellah BH, Josselin N, Chappard D, Weiss P, Layrolle P. Inflammatory reaction in rats muscle after implantation of biphasic calcium phosphate micro particles. J Mater Sci Mater Med 2007;18:287-94.
18. Kruyt MC, Wilson CE, de Bruijn JD, etal. The effect of cell-based bone tissue engineering in a goat transverse process model. Biomaterials 2006;27:5099-106.
19. Ryu HS, Hong KS, Lee JK, etal. Magnesia-doped HA/beta-TCP ceramics and evaluation of their biocompatibility. Biomaterials 2004;25:393-401.
20. Byun IS, Sarkar SK, Anirban JM, etal. Initial biocompatibility and enhanced osteoblast response of Si doping in a porous BCP bone graft substitute. J Mater Sci Mater Med 2010;21:1937-47.
21. Lu J, Blary MC, Vavasseur S, Descamps M, Anselme K, Hardouin P. Relationship between bioceramics sintering and micro-particles-induced cellular damages. J Mater Sci Mater Med 2004;15:361-5.
22. Eanes ED, Gillessen IH, Posner AS. Intermediate states in the precipitation of hydroxyapatite. Nature 1965;208:365-7.
23. ISO. ISO 10993-12: biological evaluation of medical devices-Part 12: sample preparation and reference materials. ISO 10993-12:2007, International Organization for Standardization, 2007.
24. Aktas M, Radke TF, Strauer BE, Wernet P, Kogler G. Separation of adult bone marrow mononuclear cells using the automated closed separation system Sepax. Cytotherapy 2008;10:203-11.
25. Baginski ES, Marie SS, Clark WL, Zak B. Direct microdetermination of serum calcium. Clin Chim Acta 1973;46:49-54.
26. Quadri MA, Srivastava RK. Micro-determination of inorganic phosphorus and alkaline phosphatase activity in biological fluids. Arch Exp Veterinarmed 1980;34:667-72.
27. De-Deus G, Canabarro A, Alves G, Linhares A, Senne MI, Granjeiro JM. Optimal cytocompatibility of a bioceramic nanoparticulate cement in primary human mesenchymal cells. J Endod 2009;35:1387-90.
28. Orlovskii VP, Komlev VS, Barinov SM. Hydroxyapatite and hydroxyapatite-based ceramics. Inorg Mater 2002;38:973-84.
29. Habibovic P, Yuan H, van der Valk CM, Meijer G, van Blitterswijk CA, de Groot K. 3D microenvironment as essential element for osteoinduction by biomaterials. Biomaterials 2005;26:3565-75.
30. Bruder SP, Jaiswal N, Ricalton NS, Mosca JD, Kraus KH, Kadiyala S. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res 1998;(Suppl. 355):S247-S256.
31. Kraus KH, Kirker-Head C. Mesenchymal stem cells and bone regeneration. Vet Surg 2006;35:232-42.
32. Scudiero DA, Shoemaker RH, Paull KD, etal. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988;48:4827-33.
33. Hensley K, Robinson KA, Gabbita SP, Salsman S, Floyd RA. Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med 2000;28:1456-62.
34. Repetto G, del Peso A, Zurita JL. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc 2008;3:1125-31.
35. Arcos D, Sanchez-Salcedo S, Izquierdo-Barba I, Ruiz L, Gonzalez-Calbet J, Vallet-Regi M. Crystallochemistry, textural properties, and in vitro biocompatibility of different silicon-doped calcium phosphates. J Biomed Mater Res A 2006;78:762-71.